cdmo.directory
Home
Fujifilm Pharmaceuticals U.S.A., Inc logo

Fujifilm Pharmaceuticals U.S.A., Inc

Liposome and LNP CDMO with bench-to-commercial GMP manufacturing and mRNA expertise.

CDMO specializing in liposome and lipid nanoparticle (LNP) formulation development and GMP manufacturing from bench to commercial scale, with mRNA process development and aseptic fill-finish capabilities.

Modalities

Development & manufacturing

Structured CDMO capabilities from verified public sources.

Fill-finish formats

Services

Indications

About this organization

FUJIFILM Pharmaceuticals U.S.A., Inc is a contract development and manufacturing organization (CDMO) providing integrated drug delivery and manufacturing services. The company specializes in:

Core Capabilities:

  • Liposome formulation design, process development, and scale-up manufacturing with high-potency API handling
  • Lipid nanoparticle (LNP) bench-to-commercial scale manufacturing for improved efficacy and safety
  • mRNA process development and scale-up expertise
  • GMP manufacturing with upstream and downstream processing, aseptic fill-and-finish, and batch release testing
  • Proprietary ionizable lipid library for pH-responsive nucleic acid delivery

Service Scope: One-stop service provider offering formulation development tailored to project phase, from small-scale research through commercial manufacturing. The company leverages Fujifilm's global expertise in nano drug delivery technologies and life science solutions to support therapeutic development from discovery through commercialization.

Similar profiles by shared services, modalities, and capabilities.

Submit a verified review for this organization.

Markdown mirror: /companies/fujifilmpharma.md